glp-1 gip therapy alternatives after discontinuation TrimRX GLP-1 Agonists For Obesity In

not using GLP-1 receptor agonists had significantly lower relative risks for mortality and respiratory failure, according to a presentation at the CHEST Annual Meeting.In a retrospective study, Saud Alawad, MBBS, third-year internal medicine resident at West Virginia University, and colleagues analyzed adults with a group 1 PAH

Studies found that the semaglutide pill works about as well for weight loss as the injectable version of semaglutide

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today approved a new indication for Wegovy (semaglutide) to reduce the risk of overweight and obese adults suffering serious heart problems or strokes.

While some ingredients show limited potential, the evidence remains nuanced and should be interpreted carefully